SCHEMBL6710122

SCHEMBL6710122

Cn1c(C(=O)Nc2ccc(Cl)cc2-c2noc(=O)[nH]2)cc2ccc(NC(=O)c3cccnc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
HTT P42858 2/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GRM4 Q14833 1/20 0.42
GRM5 P41594 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
KCNMA1 Q12791 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
GRIK1 P39086 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707880 0.92 GAA (0.42) MEN1KMT2ASMN1; SMN2HTTMAPT
SCHEMBL6710026 0.90 ROCK2 (0.41) MEN1KMT2ASMN1; SMN2HTTMAPT
SCHEMBL6713555 0.86 RXFP1 (0.46) MEN1KMT2ASMN1; SMN2GRM4RXFP1
SCHEMBL6710208 0.85 RXFP1 (0.44) MEN1KMT2ASMN1; SMN2HTTGRM4
SCHEMBL6708544 0.85 ALDH1A1 (0.47) MEN1KMT2ASMN1; SMN2HTTUSP2
SCHEMBL6707706 0.85 GRM4 (0.44) MEN1KMT2ASMN1; SMN2HTTMAPT
SCHEMBL6709012 0.83 ABL1 (0.45) MEN1KMT2AMAPTRXFP1NPC1
SCHEMBL6711593 0.83 RXFP1 (0.43) SMN1; SMN2GRM4RXFP1ALDH1A1HPGD
SCHEMBL6710298 0.83 GRM4 (0.51) MEN1KMT2AGRM4RXFP1NPC1
SCHEMBL6709891 0.83 RXFP1 (0.46) GRM4RXFP1ALDH1A1GRIK1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MEN1 4100/4885KMT2A 3181/4885SMN1; SMN2 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.